Ibex Wealth Advisors Edwards Lifesciences Corp Transaction History

Ibex Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $550,829 - $851,310	-10,510 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$71.7 - $82.09 $753,567 - $862,765	10,510 New	10,510 $2.45 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $663,755 - $813,437	-10,784 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$55.74 - $64.41 $14,715 - $17,004	-264 Reduced 2.39%	10,784 $1.99 Million
Q1 2019 May 01, 2019	BUY	$47.89 - $64.05 $529,088 - $707,624	11,048 New	11,048 $2.11 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ibex Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Ibex Wealth Advisors with notifications on news.